We think Eli Lilly is using state law to enforce the terms of the FDCA [Federal Food, Drug, and Cosmetic Act], which is a task generally reserve[d] to the FDA, Altman wrote, adding that the court will not allow Lilly to use state law as a back door to private enforce the FDCA. As the Supreme Court has made clear, the FDCA and its regulations provide the United States with nearly exclusive enforcement authority, the judges ruling states
doi: 10.1021/acschemneuro.8b00151 71 TorekovSSMaLGrarupNHartmannBHainerovaIAKielgastUet al
No, the FDA and Novo Nordisk do not endorse the small-dose administration of semaglutide due to insufficient clinical trials validating its effectiveness and safety
There is no known cure, and the disease can sometimes result in life-threatening and severe complications
Do not adjust your medication yourself
Fuentes Wall, B., Stephens, F., Constantin-Teodosiu, D., Marmuthu, K., Macdonald, I., Greenhaff, P